Literature DB >> 6576827

Sequential parenteral oral antibiotic therapy for serious infections.

J D Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6576827      PMCID: PMC1911658     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  8 in total

1.  High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children.

Authors:  Y J Bryson; J D Connor; M LeClerc; S T Giammona
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

Review 2.  Etiology and medical management of acute suppurative bone and joint infections in pediatric patients.

Authors:  M A Jackson; J D Nelson
Journal:  J Pediatr Orthop       Date:  1982-08       Impact factor: 2.324

3.  Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases.

Authors:  W Rodriguez; S Ross; W Khan; D McKay; P Moskowitz
Journal:  Am J Dis Child       Date:  1977-10

4.  Clindamycin treatment of osteomyelitis and septic arthritis in children.

Authors:  R D Feigin; L K Pickering; D Anderson; R E Keeney; P G Shackleford
Journal:  Pediatrics       Date:  1975-02       Impact factor: 7.124

5.  Comparative pharmacokinetics of bacampicillin and ampicillin suspensions in infants and children.

Authors:  C M Ginsburg; G H McCracken; J Clahsen; T Zweighaft
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

6.  Pharmacokinetic comparison of oral bacampicillin and parenteral ampicillin.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

Review 7.  The pharmacokinetics of bacampicillin.

Authors:  H C Neu
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

8.  Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.

Authors:  J D Nelson; R W Bucholz; H Kusmiesz; S Shelton
Journal:  J Pediatr Orthop       Date:  1982-08       Impact factor: 2.324

  8 in total
  1 in total

1.  The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas.

Authors:  C Jorup-Rönström; S Britton; A Gavlevik; K Gunnarsson; A C Redman
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.